Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Prostate Cancer

Free Subscription Articles published in JAMA Retrieve available abstracts of 41 articles: HTML format

Single Articles

February 2021
1. WEINER JS
   Enjoy the Vase.
   JAMA. 2021;325:629.
   PubMed    
   
   
   January 2021
2. JAKLEVIC MC
   Imaging Drug for Prostate Cancer.
   JAMA. 2021;325:214.
   PubMed    
   
   
   November 2020
3. ALDUBAYAN SH, Conway JR, Camp SY, Witkowski L, et al
   Detection of Pathogenic Variants With Germline Genetic Testing Using Deep Learning vs Standard Methods in Patients With Prostate Cancer and Melanoma.
   JAMA. 2020;324:1957-1969.
   PubMed     Abstract available
   
   
   
4. FEERO WG
   Bioinformatics, Sequencing Accuracy, and the Credibility of Clinical Genomics.
   JAMA. 2020;324:1945-1947.
   PubMed    
   
   
   
5. DEKA R, Courtney PT, Parsons JK, Nelson TJ, et al
   Association Between African American Race and Clinical Outcomes in Men Treated for Low-Risk Prostate Cancer With Active Surveillance.
   JAMA. 2020;324:1747-1754.
   PubMed     Abstract available
   
   
   
6. SHEN X, Pettaway CA, Chen RC
   Active Surveillance for Black Men With Low-Risk Prostate Cancer.
   JAMA. 2020;324:1733-1734.
   PubMed    
   
   
   October 2020
7. SLOMSKI A
   No Mortality Differences Among Localized Prostate Cancer Treatments.
   JAMA. 2020;324:1599.
   PubMed    
   
   
   June 2020
8. SLOMSKI A
   Prostate Cancer Drug Degarelix Rapidly Treats Pedophilic Disorder.
   JAMA. 2020;323:2453.
   PubMed    
   
   
   
9. PARSONS JK, Pierce JP, Marshall JR
   Vegetable Consumption and Progression of Prostate Cancer-Reply.
   JAMA. 2020;323:2530.
   PubMed    
   
   
   
10. CSIZMADI I, Lin PH, Freedland SJ
    Vegetable Consumption and Progression of Prostate Cancer.
    JAMA. 2020;323:2529-2530.
    PubMed    
    
    
    
11. KERLEY CP
    Vegetable Consumption and Progression of Prostate Cancer.
    JAMA. 2020;323:2528-2529.
    PubMed    
    
    
    May 2020
12. ABBASI J
    PET-CT Improved High-risk Prostate Cancer Staging in Trial.
    JAMA. 2020;323:1764.
    PubMed    
    
    
    January 2020
13. HOFFMAN KE, Penson DF, Zhao Z, Huang LC, et al
    Patient-Reported Outcomes Through 5 Years for Active Surveillance, Surgery, Brachytherapy, or External Beam Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer.
    JAMA. 2020;323:149-163.
    PubMed     Abstract available
    
    
    
14. PARSONS JK, Zahrieh D, Mohler JL, Paskett E, et al
    Effect of a Behavioral Intervention to Increase Vegetable Consumption on Cancer Progression Among Men With Early-Stage Prostate Cancer: The MEAL Randomized Clinical Trial.
    JAMA. 2020;323:140-148.
    PubMed     Abstract available
    
    
    December 2019
15. RUBIN R
    Assessing Whether Infertile Men Have a Higher Risk of Prostate Cancer.
    JAMA. 2019 Dec 4. pii: 2757280. doi: 10.1001/jama.2019.19203.
    PubMed    
    
    
    October 2019
16. ABBASI J
    Gold Nanoshells Ablate Prostate Tumors.
    JAMA. 2019;322:1343.
    PubMed    
    
    
    September 2019
17. HAMPTON T
    Compound in Broccoli Restores Tumor Suppressor Activity.
    JAMA. 2019;322:805-806.
    PubMed    
    
    
    May 2019
18. MAHAL BA, Huang FW
    Racial Disparities in Low-Risk Prostate Cancer-Reply.
    JAMA. 2019;321:1727-1728.
    PubMed    
    
    
    
19. EHDAIE B, Carlsson S, Vickers A
    Racial Disparities in Low-Risk Prostate Cancer.
    JAMA. 2019;321:1726-1727.
    PubMed    
    
    
    
20. POLITE BN, Gluck AR, Brawley OW
    Ensuring Equity and Justice in the Care and Outcomes of Patients With Cancer.
    JAMA. 2019;321:1663-1664.
    PubMed    
    
    
    April 2019
21. WYNER LM
    Artist, Rediscovered: Images and Ethics of Early Prostate Cancer Screening.
    JAMA. 2019;321:1236-1238.
    PubMed    
    
    
    February 2019
22. MAHAL BA, Butler S, Franco I, Spratt DE, et al
    Use of Active Surveillance or Watchful Waiting for Low-Risk Prostate Cancer and Management Trends Across Risk Groups in the United States, 2010-2015.
    JAMA. 2019 Feb 11. pii: 2724897. doi: 10.1001/jama.2018.19941.
    PubMed    
    
    
    December 2018
23. MAHAL BA, Berman RA, Taplin ME, Huang FW, et al
    Prostate Cancer-Specific Mortality Across Gleason Scores in Black vs Nonblack Men.
    JAMA. 2018;320:2479-2481.
    PubMed    
    
    
    August 2018
24. MARTIN RM
    Power of a Trial Investigating a Low-Intensity PSA-Based Screening Intervention-Reply.
    JAMA. 2018;320:600-601.
    PubMed    
    
    
    
25. PINSKY PF
    Power of a Trial Investigating a Low-Intensity PSA-Based Screening Intervention.
    JAMA. 2018;320:600.
    PubMed    
    
    
    July 2018
26. KISHAN AU, Cook RR, King CR
    Optimal Treatment for High-Risk Prostate Cancer-Reply.
    JAMA. 2018;320:405.
    PubMed    
    
    
    
27. ONG WL, Koh TL, Millar J
    Optimal Treatment for High-Risk Prostate Cancer.
    JAMA. 2018;320:404-405.
    PubMed    
    
    
    May 2018
28. LOEB S, Byrne N, Makarov DV, Lepor H, et al
    Use of Conservative Management for Low-Risk Prostate Cancer in the Veterans Affairs Integrated Health Care System From 2005-2015.
    JAMA. 2018 May 15. pii: 2681802. doi: 10.1001/jama.2018.5616.
    PubMed    
    
    
    
29. FENTON JJ, Weyrich MS, Durbin S, Liu Y, et al
    Prostate-Specific Antigen-Based Screening for Prostate Cancer: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2018;319:1914-1931.
    PubMed     Abstract available
    
    
    
30. GROSSMAN DC, Curry SJ, Owens DK, Bibbins-Domingo K, et al
    Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2018;319:1901-1913.
    PubMed     Abstract available
    
    
    
31. JIN J
    Screening for Prostate Cancer.
    JAMA. 2018;319:1946.
    PubMed    
    
    
    
32. CARTER HB
    Prostate-Specific Antigen (PSA) Screening for Prostate Cancer: Revisiting the Evidence.
    JAMA. 2018;319:1866-1868.
    PubMed    
    
    
    March 2018
33. KISHAN AU, Cook RR, Ciezki JP, Ross AE, et al
    Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer.
    JAMA. 2018;319:896-905.
    PubMed     Abstract available
    
    
    
34. MARTIN RM, Donovan JL, Turner EL, Metcalfe C, et al
    Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality: The CAP Randomized Clinical Trial.
    JAMA. 2018;319:883-895.
    PubMed     Abstract available
    
    
    
35. BARRY MJ
    Screening for Prostate Cancer: Is the Third Trial the Charm?
    JAMA. 2018;319:868-869.
    PubMed    
    
    
    December 2017
36. MATULEWICZ RS, Weiner AB, Schaeffer EM
    Active Surveillance for Prostate Cancer.
    JAMA. 2017;318:2152.
    PubMed    
    
    
    June 2017
37. LITWIN MS, Tan HJ
    The Diagnosis and Treatment of Prostate Cancer: A Review.
    JAMA. 2017;317:2532-2542.
    PubMed     Abstract available
    
    
    April 2017
38. BIBBINS-DOMINGO K, Grossman DC, Curry SJ
    The US Preventive Services Task Force 2017 Draft Recommendation Statement on Screening for Prostate Cancer: An Invitation to Review and Comment.
    JAMA. 2017 Apr 11. doi: 10.1001/jama.2017.4413.
    PubMed    
    
    
    March 2017
39. BAROCAS DA, Alvarez J, Resnick MJ, Koyama T, et al
    Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years.
    JAMA. 2017;317:1126-1140.
    PubMed     Abstract available
    
    
    
40. CHEN RC, Basak R, Meyer AM, Kuo TM, et al
    Association Between Choice of Radical Prostatectomy, External Beam Radiotherapy, Brachytherapy, or Active Surveillance and Patient-Reported Quality of Life Among Men With Localized Prostate Cancer.
    JAMA. 2017;317:1141-1150.
    PubMed     Abstract available
    
    
    
41. HAMDY FC, Donovan JL
    Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer: Helping Decision Making for Patients and Their Physicians.
    JAMA. 2017;317:1121-1123.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: